Dimethyl fumarate-associated lymphopenia: Risk factors and clinical significance.

Longbrake, Erin E; Naismith, Robert T; Parks, Becky J; Wu, Gregory F; Cross, Anne H

Longbrake, Erin E; Naismith, Robert T; Parks, Becky J; Wu, Gregory F; Cross, Anne H.

Afiliação

Longbrake EE; Washington University in St. Louis, Department of Neurology, 660 S. Euclid Ave., Campus Box 8111, St. Louis, MO 63110, USA.
Naismith RT; Department of Neurology, Washington University in St. Louis, USA.
Parks BJ; Department of Neurology, Washington University in St. Louis, USA.
Wu GF; Department of Neurology, Washington University in St. Louis, USA.
Cross AH; Department of Neurology, Washington University in St. Louis, USA.

Mult Scler J Exp Transl Clin ; 12015.

Article em En | MEDLINE | ID: mdl-26550483

Palavras-chave

Multiple sclerosis; dimethyl fumarate; drug safety; lymphopenia; progressive multifocal leukoencephalopathy

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Mult Scler J Exp Transl Clin Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google